CommercialMedicare AdvantageMedicaidDecember 31, 2023
HEDIS diabetes documentation
HEDIS® 2023 documentation for Blood Pressure Control for Patients With Diabetes (BPD)
Measure description
The percentage of members 18 to 75 years of age with diabetes (types 1 and 2) whose blood pressure (BP) was adequately controlled (< 140/90 mm Hg) during the measurement year.
What we are looking for in provider records:
- Last BP documented in 2023 regardless of reading
- Evidence of hospice or palliative services in 2023
- Evidence patient expired in 2023
- Documentation of polycystic ovarian syndrome, gestational diabetes, or steroid induced diabetes
Helpful hints:
- Take a second BP at the end of the office visit if initial BP was > 140/90.
- Consider taking BP at every visit.
- Counsel on healthy habits for managing high blood pressure.
- Encourage medication adherence.
- Member-reported BPs during a telehealth visit are acceptable.
- Review diabetic services needed at each office visit.
- For members who have not been diagnosed with diabetes but take a diabetes medication for off-label use, document why they are taking medication (for example, weight loss, congestive heart failure, chronic kidney disease, etc.).
HEDIS 2023 documentation for Hemoglobin A1c Control for Patients With Diabetes (HBD)
Measure description
The percentage of members 18 to 75 years of age with diabetes (types 1 and 2) whose hemoglobin A1c (HbA1c) was at the following levels during the measurement year:
- HbA1c control (< 8.0%)
- HbA1c poor control (> 9.0%)
What we are looking for in provider records:
- Last HbA1c documented in 2023 regardless of result
- Evidence of hospice or palliative services in 2023
- Evidence patient expired in 2023
- Documentation of polycystic ovarian syndrome, gestational diabetes, or steroid induced diabetes
Helpful hints:
- Counsel on healthy habits for managing diabetes.
- If appropriate, set an HbA1c goal of less than 7%.
- Encourage timely HbA1c testing.
- Encourage medication adherence.
- Encourage continuous glucose monitoring.
- In progress notes when documenting HbA1c value include date the test was performed.
- Review diabetic services needed at each office visit.
- For members who have not been diagnosed with diabetes but take a diabetes medication for off-label use, document why they are taking medication (for example, weight loss, congestive heart failure, chronic kidney disease, etc.).
HEDIS 2023 documentation for Eye Exam for Patients With Diabetes (EED)
Measure description
The percentage of members 18 to 75 years of age with diabetes (types 1 and 2) who had a retinal eye exam.
What we are looking for in provider records:
- Evidence of a retinal eye exam by an eye care professional (optometrist or ophthalmologist) in the measurement year or year prior with results
- Bilateral eye enucleation any time during the member’s history
- Evidence of hospice or palliative services in 2023
- Evidence patient expired in 2023
- Documentation of polycystic ovarian syndrome, gestational diabetes, or steroid induced diabetes
Helpful hints:
- Refer patients to an optometrist or ophthalmologist for a dilated or retinal eye exam annually.
- Fundus/retinal photography is considered imaging and is eligible for use; must be dated and interpreted by an eye care professional.
- Counsel on healthy habits for managing diabetes.
- In progress notes when documenting a retinal eye exam include the name of eye care provider or optometrist/ophthalmologist credentials, date performed, and result.
- Encourage medication adherence.
- Review diabetic services needed at each office visit.
- For members who have not been diagnosed with diabetes but take a diabetes medication for off-label use, document why they are taking medication (for example, weight loss, congestive heart failure, chronic kidney disease, etc.).
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).
Medicaid services provided by Anthem Blue Cross and Blue Shield HP, trade name of Anthem HP, LLC.
Medicare services provided by Anthem Blue Cross and Blue Shield, trade name of Anthem HealthChoice HMO, Inc. and Anthem HealthChoice Assurance, Inc., Anthem Blue Cross and Blue Shield HP, trade name of Anthem HP, LLC., or Anthem Blue Cross and Blue Shield Retiree Solutions, trade name of Anthem Insurance Companies, Inc.
Commercial services provided by Anthem Blue Cross and Blue Shield, trade name of Anthem HealthChoice HMO, Inc. and Anthem HealthChoice Assurance, Inc., or Anthem Blue Cross and Blue Shield HP, trade name of Anthem HP, LLC.
Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
NYBCBS-CDCRCM-041661-23-CPN41092
PUBLICATIONS: February 2024 Provider Newsletter
To view this article online:
Visit https://providernews.anthem.com/new-york/articles/hedis-diabetes-documentation-17571-17571
Or scan this QR code with your phone